Catalyst Wire Dossier Catalyst Wire Dossier

Tavocept

· BioNumerik Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Tavocept, covering 2022-07-13 to 2022-07-13. Get the full timeline:

Most recent: Clinical Trial Update: Phase 3 Study of Tavocept Versus Placebo in Patients With Newly Diagnosed or Relapsed Advanced Primary Adenocarcinoma of the Lung Treated With Docetaxel or Paclitaxel Plus Cisplatin [Phase 3]

See pricing